Skip to main content

Find Clinical Trials

Home
Conditions
High Grade Gliomas

Clinical trial condition

High Grade Gliomas

Explore clinical trials studying High Grade Gliomas. Study availability and eligibility vary by location and protocol.

17 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

High Grade Gliomas trial results

Not Yet Recruiting

Gallium Maltolate for the Treatment of Pediatric Patients With Relapsed or Refractory Pediatric High-Grade Glioma and Atypical Teratoid Rhabdoid Tumor

NCT07331064

Conditions: Atypical Teratoid Rhabdoid Tumors (ATRT), Brain Diseases, Brain Neoplasms, +26 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Determine Maximum Tolerated Dose, Safety, and Tolerability of Rhenium (186Re) in Pediatric Recurrent, Refractory or Progressive Ependymoma and High-Grade Glioma

NCT07061626

Conditions: Ependymoma, Glioma, High Grade Gliomas, +7 more
Locations: Not specified

View Trial Details

Completed

SM-1 Combined With Temozolomide in Subjects With Refractory or Recurrent High-Grade Gliomas

NCT07635173

Conditions: Astrocytoma, Glioblastoma, Glioblastomas (GBM), +9 more
Locations: Beijing Tiantan Hospital, Capital Medical University Beijing, Beijing Municipality, China

View Trial Details

Completed

Short Course of Radiation for Gliomas in Elderly Patients

NCT00386919

Conditions: High Grade Gliomas
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors

NCT00302159

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

Virginia Commonwealth University Richmond, Virginia, United States

View Trial Details

Completed

Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection

NCT00918281

Conditions: Adenocarcinoma, Breast Cancer, Breast Diseases, +31 more
Locations: 101 Carnegie Center Princeton, New Jersey, United States

View Trial Details

Completed

Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5

NCT00743353

Conditions: Astrocytoma, Breast Cancer, Breast Diseases, +29 more
Locations: Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details